Market Definition

An exoskeleton refers to a wearable mechanical device desiged to enhance human strength, mobility, and endurance by supporting or augmenting body movements. The market spans medical, industrial, and military applications, including mobility assistance, rehabilitation, and load-bearing support.

It is used to aid patients with mobility impairments, reduce worker fatigue, and enhance physical performance in demanding environments.

Exoskeleton Market Overview

The global exoskeleton market size was valued at USD 478.2 million in 2024 and is projected to grow from USD 551.2 million in 2025 to USD 1,699.2 million by 2032, exhibiting a CAGR of 17.45% during the forecast period.

Market growth is driven by increasing rehabilitation needs due to mobility impairments and neurological disorders, with robotic technologies enhancing therapy effectiveness. AI integration is advancing these systems by enabling real-time adaptation and personalized support across healthcare and industrial applications.

Major companies operating in the exoskeleton industry are Myomo Inc., Rex Bionics Ltd, Ekso Bionics, Cyberdyne USA Inc., Comau S.p.A, DIH Medical, HYUNDAI MOTOR GROUP, Ottobock, Laevo BV, Lifeward, Inc., B-Temia, German Bionic Systems GmbH, Hocoma, ABLE Human Motion, and Fourier.

Market expansion is fueled by increasing adoption in industrial environments to reduce worker fatigue and prevent occupational injuries. With rising concerns over musculoskeletal disorders caused by repetitive motions and overhead tasks, industries are integrating wearable robotic systems to support upper body movements and lower physical strain.

These exoskeletons enhance productivity, improve worker safety, and reduce long-term healthcare costs. Their ability to decrease shoulder load and muscle activity makes them a valuable solution for improving ergonomics in labor-intensive operations.

In November 2024, Hyundai Motor and Kia’s Robotics LAB launched the ‘X-ble Shoulder’ wearable robot, engineered to enhance industrial productivity and minimize musculoskeletal strain during overhead tasks. Designed for multi-industry use, the lightweight device reduces shoulder load by 60% and muscle activity by 30%, improving worker comfort.

Key Highlights:

The exoskeleton market size was recorded at USD 478.2 million in 2024.
The market is projected to grow at a CAGR of 17.45% from 2025 to 2032.
North America held a market share of 36.55% in 2024, with a valuation of USD 174.8 million.
The mobile segment garnered USD 274.6 million in revenue in 2024.
The lower body segment is expected to reach USD 683.9 million by 2032.
The passive exoskeletons segment is anticipated to witness a CAGR of 18.39% over the forecast period.
The healthcare segment held a share of 41.23% in 2024.
Europe is anticipated to grow at a CAGR of 19.91% over the forecast period.

Market Driver

Rising Demand for Rehabilitation in Healthcare

The progress of the market is propelled by the rising demand for rehabilitation in healthcare, supported by the growing prevalence of mobility impairments, neurological disorders, and age-related conditions.

The integration of robotic and visually interactive technologies into clinical rehabilitation settings enhances patient outcomes by enabling intensive, repetitive, and task-specific therapy.

These advanced systems support the restoration of motor functions, particularly in patients recovering from strokes or spinal cord injuries, and are increasingly being adopted as essential tools for improving rehabilitation efficiency and effectiveness.

In February 2025, DIH Holding US, Inc. expanded its strategic partnership with Zahrawi Group to include Saudi Arabia, extending its collaboration to four Gulf countries. This expansion strengthens DIH’s regional presence and improves access to advanced rehabilitation technologies, supporting effective treatment of walking impairments and motor function recovery through robotic and interactive solutions.

Market Challenge

Limited Battery Life and Power Management

The exoskeleton market faces a significant challenge due to limited battery life and inefficient power management, restricting device usage duration and operational efficiency.

This is particularly critical in industrial, military, and healthcare applications where long operational periods are essential. High power consumption by power actuators and sensors leads to frequent downtime and reduced productivity.

To address this challenge, companies are developing advanced battery technologies with higher energy density and exploring energy-efficient actuators.

Some firms are also integrating regenerative braking systems and optimizing control algorithms to minimize power consumption. These innovations aim to enhance autonomy, extend usage time, and improve overall device performance.

Market Trend

Integration of AI in Exoskeleton

The market is witnessing a growing trend toward AI integration to enhance adaptability, precision, and user-specific support. Leveraging real-time motion data and contextual awareness, AI-powered exoskeletons can interpret movement patterns, anticipate user needs, and adjust assistance dynamically.

This trend is enabling more intelligent, efficient, and versatile solutions across sectors such as healthcare, logistics, and manufacturing, where real-time responsiveness and personalized support are becoming essential for improving human-machine collaboration and reducing physical strain in demanding environments.

In May 2025, German Bionic launched Exia, the world’s first exoskeleton powered entirely by Augmented AI. Built on advanced hardware and intelligent control software, Exia delivers up to 84 lbs. of dynamic lift assistance. It adapts in real time using insights from billions of motion data points, offering universal application across industries with enhanced strength, precision, and responsiveness.

Exoskeleton Market Report Snapshot

Segmentation	Details
By Product Type	Mobile, Stationary
By Extremity	Lower Body, Upper Body, Full Body
By Technology	Powered Exoskeletons, Passive Exoskeletons
By End-use Industry	Healthcare, Industrial, Military & Defense, Others
By Region	North America: U.S., Canada, Mexico
	Europe: France, UK, Spain, Germany, Italy, Russia, Rest of Europe
	Asia-Pacific: China, Japan, India, Australia, ASEAN, South Korea, Rest of Asia-Pacific
	Middle East & Africa: Turkey, U.A.E., Saudi Arabia, South Africa, Rest of Middle East & Africa
	South America: Brazil, Argentina, Rest of South America

Market Segmentation

By Product Type (Mobile and Stationary): The mobile segment earned USD 274.6 million in 2024, mainly due to rising demand for wearable and portable exoskeletons across healthcare, industrial, and defense applications that require mobility and flexibility.
By Extremity (Lower Body, Upper Body, and Full Body): The lower body segment held a share of 43.23% in 2024, fueled by its widespread use in rehabilitation therapy and mobility support for patients with spinal cord injuries and lower limb disabilities.
By Technology (Powered Exoskeletons and Passive Exoskeletons): The powered exoskeletons segment is projected to reach USD 912.9 million by 2032, owing to its superior strength augmentation, enhanced mobility support, and expanding applications in industrial automation and military operations.
By End-use Industry (Healthcare, Industrial, Military & Defense, and Others): The healthcare segment held a share of 41.23% in 2024, propelled by the increasing adoption of exoskeletons for rehabilitation, post-stroke therapy, and mobility assistance for patients with neurological and musculoskeletal disorders.

Exoskeleton Market Regional Analysis

Based on region, the global market has been classified into North America, Europe, Asia Pacific, Middle East & Africa, and South America.

The North America exoskeleton market share stood at around 36.55% in 2024, valued at USD 174.8 million. This dominance is reinforced by the presence of localized manufacturing facilities that streamline supply chains, reduce costs, and ensure compliance with domestic standards.

Proximity to end-users enables faster product deployment and customization, supporting broader adoption across healthcare, industrial, and logistics sectors. This localized strategy enhances operational efficiency and accelerates commercialization, positioning North America as a key hub for innovation and growth.

In October 2023, ErgoSanté commenced exoskeleton production in the USA, through its subsidiary, HAPO USA Corporation, with the launch of its first “Made in USA” unit from its Wilmington, North Carolina facility. This supports the company’s international expansion and enhances services to the American market through localized manufacturing.

The Europe exoskeleton industry is estimated to grow at a robust CAGR of 19.91% over the forecast period. This expansion is fueled by advancements in personal mobility solutions targeting individuals with severe impairments.

The introduction of self-balancing exoskeletons that support natural gait and enable essential movements such as walking, bending, and reaching is expanding the use of these devices in rehabilitation and independent living.

Increasing clinical trials and innovation in design are boosting wider adoption across healthcare settings, addressing the demand for effective mobility aids and improving user autonomy and quality of life.

In February 2025, Wandercraft launched a landmark clinical trial for its Personal Exoskeleton, the world’s first self-balancing model for individual use. Designed to restore mobility for those with severe impairments, it enables upright movement, walking, bending, and reaching.

Regulatory Frameworks

In the U.S., the Food and Drug Administration (FDA) regulates medical exoskeletons to ensure their safety, effectiveness, and compliance with relevant medical device standards.
In India, the Central Drugs Standard Control Organisation (CDSCO) regulates exoskeletons under the Medical Devices Rules 2017, covering classification, approval, manufacturing licensing, and post-market surveillance.

Competitive Landscape

Key players in the exoskeleton market are actively adopting strategies such as mergers and acquisitions, partnerships, and new product launches to strengthen their market positions. These companies are expanding their portfolios and geographic reach through strategic collaborations and targeted acquisitions.

Continuous innovation is supported by frequent introductions of advanced exoskeleton models designed to address diverse applications. This dynamic competitive landscape reflects a concerted effort by industry leaders to capitalize on emerging opportunities and enhance their market share globally.

In January 2025, DIH Holding US, Inc. partnered with Nobis Rehabilitation Partners to deploy the Andago overground gait and balance training device across all newly established hospitals. This strategic collaboration aims to a strategic advancement in exoskeleton-assisted rehabilitation by enhancing mobility therapy for patients with gait, balance, and upper limb impairments through robotics-driven functional training and clinical research.

List of Key Companies in Exoskeleton Market:

Myomo Inc.
Rex Bionics Ltd
Ekso Bionics
Cyberdyne USA Inc.
Comau S.p.A
DIH Medical
HYUNDAI MOTOR GROUP
Ottobock
Laevo BV
Lifeward, Inc.
B-Temia
German Bionic Systems GmbH
Hocoma
ABLE Human Motion
Fourier

Recent Developments (M&A/Partnerships)

In June 2024, Skelex BV acquired the global rights to the Ironhand exoskeleton from Bioservo AB, expanding its portfolio with active hand-support technology. This strategic move enhances Skelex’s industrial exoskeleton offerings, complementing its existing shoulder and back solutions, and strengthens its position in delivering advanced, technology-driven wearable support systems for hand-intensive tasks across global industrial applications.
In June 2024, Ekso Bionics partnered with Shepherd Center to integrate its EksoNR and Ekso Indego exoskeletons across the hospital’s rehabilitation and community network. The collaboration focused on developing a research and training program to enhance clinical implementation and personal use, advancing best practices in exoskeleton-assisted recovery for complex neurological and mobility-related conditions.
In April 2023, Hyundai Motor partnered with Asan Medical Center and the National Rehabilitation Center in Korea to deploy its wearable robot, ‘X-ble MEX,’ for patient rehabilitation. The certified device supported paraplegic patients by enhancing mobility.